Pasithea Therapeutics Corp. (NASDAQ:KTTA) filed a Form 8-K with the Securities and Exchange Commission on February 20, 2026, disclosing a material event.
Pasithea Therapeutics Corp.'s stock currently trades at $0.80 with a market capitalization of $8.4M. The Healthcare company's stock moved following the disclosure.